Search Results

There are 14030 results for: content related to: Application of a propensity score to adjust for channelling bias with NSAIDs

  1. Abstracts of the 20th International Conference on Pharmacoepidemiology (ICPE) & Therapeutic Risk Management. Bordeaux, France, 22 - 25 August, 2004

    Pharmacoepidemiology and Drug Safety

    Volume 13, Issue S1, July 2004, Pages: S1–S349,

    Version of Record online : 23 SEP 2004, DOI: 10.1002/pds.987

  2. You have free access to this content
    Nonsteroidal anti-inflammatory drugs and the risk of nonmelanoma skin cancer

    International Journal of Cancer

    Volume 137, Issue 1, 1 July 2015, Pages: 144–153, Daphne Reinau, Christian Surber, Susan S. Jick and Christoph R. Meier

    Version of Record online : 3 DEC 2014, DOI: 10.1002/ijc.29357

  3. Abstracts of the 23rd International Conference on Pharmacoepidemiology & Therapeutic Risk Management

    Pharmacoepidemiology and Drug Safety

    Volume 16, Issue S2, July 2007, Pages: S1–S274,

    Version of Record online : 7 AUG 2007, DOI: 10.1002/pds.1461

  4. You have free access to this content
    Safety of Etoricoxib, Celecoxib, and Nonselective Nonsteroidal Antiinflammatory Drugs in Ankylosing Spondylitis and Other Spondyloarthritis Patients: A Swedish National Population-Based Cohort Study

    Arthritis Care & Research

    Volume 67, Issue 8, August 2015, Pages: 1137–1149, L. E. Kristensen, A. K. Jakobsen, J. Askling, F. Nilsson and L. T. H. Jacobsson

    Version of Record online : 26 JUL 2015, DOI: 10.1002/acr.22555

  5. Risk of myocardial infarction associated with selective COX-2 inhibitors: Meta-analysis of randomised controlled trials

    Pharmacoepidemiology and Drug Safety

    Volume 16, Issue 7, July 2007, Pages: 762–772, Li-Chia Chen and Darren M Ashcroft

    Version of Record online : 25 APR 2007, DOI: 10.1002/pds.1409

  6. NSAID Action and the Foundations for Cardiovascular Toxicity

    Cardiotoxicity of Non-Cardiovascular Drugs

    Anna L. Blobaum, Lawrence J. Marnett, Pages: 257–285, 2010

    Published Online : 9 APR 2010, DOI: 10.1002/9780470660379.ch8

  7. You have free access to this content
    Defects in mouse nephrogenesis induced by selective and non-selective cyclooxygenase-2 inhibitors

    British Journal of Pharmacology

    Volume 163, Issue 5, July 2011, Pages: 927–936, Anke Olliges, Stefanie Wimmer and Rolf M Nüsing

    Version of Record online : 8 JUN 2011, DOI: 10.1111/j.1476-5381.2011.01313.x

  8. ABSTRACTS: 1st International Conference on Therapeutic Risk Management & 19th International Conference on Pharmacoepidemiology, Philadelphia, Pennsylvania, USA, 21–24 August, 2003

    Pharmacoepidemiology and Drug Safety

    Volume 12, Issue S1, August 2003, Pages: S1–S189,

    Version of Record online : 21 JUL 2017, DOI: 10.1002/pds.2003.12.s1.s1

  9. Impact of COX-2 Inhibitors in Thai Orthopaedic Outpatients

    Journal of Pharmacy Practice and Research

    Volume 35, Issue 2, June 2005, Pages: 115–118, Jitsuda Phosri, Vithaya Kulsomboon and Niyada Kiatying-Angsulee

    Version of Record online : 13 APR 2015, DOI: 10.1002/j.2055-2335.2005.tb00320.x

  10. Non-aspirin NSAIDs, cyclooxygenase-2 inhibitors and risk for cardiovascular events–stroke, acute myocardial infarction, and death from coronary heart disease

    Pharmacoepidemiology and Drug Safety

    Volume 18, Issue 11, November 2009, Pages: 1053–1063, Christianne L. Roumie, Neesha N. Choma, Lisa Kaltenbach, Edward F. Mitchel, Jr, Patrick G. Arbogast and Marie R. Griffin

    Version of Record online : 27 JUL 2009, DOI: 10.1002/pds.1820

  11. You have free access to this content
    Adherence to gastroprotection during cyclooxygenase 2 inhibitor treatment and the risk of upper gastrointestinal tract events: A population-based study

    Arthritis & Rheumatism

    Volume 64, Issue 8, August 2012, Pages: 2792–2802, Vera E. Valkhoff, Eva M. van Soest, Giampiero Mazzaglia, Mariam Molokhia, René Schade, Gianluca Trifiro, Jay L. Goldstein, Sonia Hernandez-Diaz, Ernst J. Kuipers and Miriam C. J. M. Sturkenboom

    Version of Record online : 27 JUL 2012, DOI: 10.1002/art.34433

  12. Abstracts of the 22nd International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Lisbon, Portugal, 24–27 August 2006

    Pharmacoepidemiology and Drug Safety

    Volume 15, Issue S1, August 2006, Pages: S1–S316,

    Version of Record online : 1 AUG 2006, DOI: 10.1002/pds.1295

  13. COX-2 inhibitors: complex association with lower risk of hospitalization for gastrointestinal events compared to traditional NSAIDs plus proton pump inhibitors

    Pharmacoepidemiology and Drug Safety

    Volume 18, Issue 10, October 2009, Pages: 880–890, Michiel W. van der Linden, Sabine Gaugris, Ernst J. Kuipers, Myrthe P. P. van Herk-Sukel, Bart J. F. van den Bemt, Shuvayu S. Sen and Ron M. C. Herings

    Version of Record online : 10 JUL 2009, DOI: 10.1002/pds.1782

  14. Cardiovascular and Gastrointestinal Safety of NSAIDs: A Systematic Review of Meta-Analyses of Randomized Clinical Trials

    Clinical Pharmacology & Therapeutics

    Volume 89, Issue 6, June 2011, Pages: 855–866, F Salvo, A Fourrier-Réglat, F Bazin, P Robinson, N Riera-Guardia, M Haag, AP Caputi, N Moore, MC Sturkenboom, A Pariente and on behalf of investigators of the Safety of Non-Steroidal Anti-Inflammatory Drugs: The SOS Project

    Version of Record online : 6 APR 2011, DOI: 10.1038/clpt.2011.45

  15. Abstracts of the 24th International Conference on Pharmacoepidemiology & Therapeutic Risk Management

    Pharmacoepidemiology and Drug Safety

    Volume 17, Issue S1, August 2008, Pages: S1–S294,

    Version of Record online : 13 AUG 2008, DOI: 10.1002/pds.1631

  16. You have full text access to this Open Access content
    The Coxib NSAIDs: Potential Clinical and Pharmacologic Importance in Veterinary Medicine

    Journal of Veterinary Internal Medicine

    Volume 19, Issue 5, September 2005, Pages: 633–643, Mary Sarah Bergh and Steven C. Budsberg

    Version of Record online : 5 FEB 2008, DOI: 10.1111/j.1939-1676.2005.tb02741.x

  17. Clinical Implications of Drug Interactions with Coxibs

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 21, Issue 10, October 2001, Pages: 1223–1232, William R. Garnett

    Version of Record online : 17 JAN 2012, DOI: 10.1592/phco.21.15.1223.33891

  18. Abstracts of the 21st International Conference on Pharmacepidemiology & Therapeutic Risk Management

    Pharmacoepidemiology and Drug Safety

    Volume 14, Issue S2, September 2005, Pages: S1–S218,

    Version of Record online : 15 AUG 2005, DOI: 10.1002/pds.1136

  19. You have free access to this content
    Non-steroidal anti-inflammatory drugs and cardiac failure: meta-analyses of observational studies and randomised controlled trials

    European Journal of Heart Failure

    Volume 10, Issue 11, November 2008, Pages: 1102–1107, Paul A Scott, Gabrielle H. Kingsley and David L Scott

    Version of Record online : 21 OCT 2008, DOI: 10.1016/j.ejheart.2008.07.013

  20. Prescriber adoption of newly approved selective COX-2 inhibitors

    Pharmacoepidemiology and Drug Safety

    Volume 17, Issue 12, December 2008, Pages: 1168–1174, Deborah Layton, Patrick C. Souverein, Eibert R Heerdink, Saad AW Shakir and AGC Egberts

    Version of Record online : 29 SEP 2008, DOI: 10.1002/pds.1667